Fate Therapeutics
FATE
NZ$1.91
Share price
-0.86%
Change (1 day)
-65.56%
Change (1 year)
Categories
Fate Therapeutics (FATE) - Total liabilities
Total liabilities on the balance sheet as of March 2025 : NZ$0.18 Billion
According to Fate Therapeutics 's latest financial reports the company's total liabilities are NZ$0.18 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Fate Therapeutics - Total liabilities on balance sheet (from 2012 to 2025)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2024-12-31 | NZ$0.21 B | -0.75% |
| 2023-12-31 | NZ$0.21 B | -37.58% |
| 2022-12-31 | NZ$0.34 B | -1.73% |
| 2021-12-31 | NZ$0.35 B | 7.68% |
| 2020-12-31 | NZ$0.32 B | 286.24% |
| 2019-12-31 | NZ$85.4 M | 8.99% |
| 2018-12-31 | NZ$78.36 M | 98.03% |
| 2017-12-31 | NZ$39.57 M | 25.19% |
| 2016-12-31 | NZ$31.6 M | -27.7% |
| 2015-12-31 | NZ$43.71 M | 49.95% |
| 2014-12-31 | NZ$29.15 M | 405.98% |
| 2013-12-31 | NZ$5.76 M | -92.58% |
| 2012-12-31 | NZ$77.67 M | 3.57% |
| 2011-12-31 | NZ$75 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Sarepta Therapeutics
SRPT | NZ$3.86 B | 2,006.51% | 🇺🇸 USA |
 Becton Dickinson BDX | NZ$48.64 B | 26,406.20% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | NZ$4.72 B | 2,476.75% | 🇺🇸 USA |
 Avidity Biosciences RNA | NZ$0.21 B | 18.22% | 🇺🇸 USA |
 Neurocrine Biosciences
NBIX | NZ$1.91 B | 944.79% | 🇺🇸 USA |